Bohm Lee
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Bohm Lee has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Yongcheol Cho
Department of Brain Sciences, Daegu Gyeongbuk Institute of Science & Technology (DGIST), Daegu, Republic of Korea
4 shared publications Aaron DiAntonio
Department of Developmental Biology, Washington University School of Medicine, St. Louis, Missouri, USA; Needleman Center for Neurometabolism and Axonal Therapeutics, Washington University School of Medicine, St. Louis, Missouri, USA
2 shared publicationsEunhye Cho
Department of Life Sciences, Korea University, Seoul, Republic of Korea
2 shared publicationsJung Eun Shin
Department of Molecular Neuroscience, Dong-A University College of Medicine, Busan 49201, Republic of Korea
2 shared publicationsYeonsoo Oh
Department of Life Sciences, Korea University, Seoul, Republic of Korea
2 shared publications- Hae Woong Choi
Division of Life Sciences, Korea University, Seoul, South Korea
1 shared publication
Latest Publications
- Open Access
- 29 January 2022
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 298 (3) , 101647
FK506-binding protein-like and FK506-binding protein 8 regulate dual leucine zipper kinase degradation and neuronal responses to axon injury
- 29 January 2022
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 298 (3) , 101647
Open AccessFK506-binding protein-like and FK506-binding protein 8 regulate dual leucine zipper kinase degradation and neuronal responses to axon injury
- Open Access
FKBPL and FKBP8 regulate DLK degradation and neuronal responses to axon injury
DLK is a key regulator of axon regeneration and degeneration in response to neuronal injury. To understand the molecular mechanisms controlling the DLK function, we performed yeast two-hybrid screening analysis and identified FKBPL as a DLK-binding protein that bound to the kinase domain and inhibited the kinase enzymatic activity of DLK. FKBPL regulated DLK stability through ubiquitin-dependent DLK degradation. We tested other members in the FKBP protein family and found that FKBP8 also induced DLK degradation as FKBPL did. We found that Lysine 271 residue in the kinase domain of DLK was a major site of ubiquitination and SUMO3-conjugation and responsible for FKBP8-mediated degradation. In vivo overexpression of FKBP8 delayed progression of axon degeneration and neuronal death following axotomy in sciatic and optic nerves, respectively, although axon regeneration efficiency was not enhanced. This research identified FKBPL and FKBP8 as new DLK-interacting proteins that regulated DLK stability by MG-132 or bafilomycin A1-sensitive protein degradation.
Open AccessFKBPL and FKBP8 regulate DLK degradation and neuronal responses to axon injury
DLK is a key regulator of axon regeneration and degeneration in response to neuronal injury. To understand the molecular mechanisms controlling the DLK function, we performed yeast two-hybrid screening analysis and identified FKBPL as a DLK-binding protein that bound to the kinase domain and inhibited the kinase enzymatic activity of DLK. FKBPL regulated DLK stability through ubiquitin-dependent DLK degradation. We tested other members in the FKBP protein family and found that FKBP8 also induced DLK degradation as FKBPL did. We found that Lysine 271 residue in the kinase domain of DLK was a major site of ubiquitination and SUMO3-conjugation and responsible for FKBP8-mediated degradation. In vivo overexpression of FKBP8 delayed progression of axon degeneration and neuronal death following axotomy in sciatic and optic nerves, respectively, although axon regeneration efficiency was not enhanced. This research identified FKBPL and FKBP8 as new DLK-interacting proteins that regulated DLK stability by MG-132 or bafilomycin A1-sensitive protein degradation.
- Open Access
- 6 January 2021
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 22 (2) , 474
Experimental Model Systems for Understanding Human Axonal Injury Responses
Neurons are structurally unique and have dendrites and axons that are vulnerable to injury. Some neurons in the peripheral nervous system (PNS) can regenerate their axons after injuries. However, most neurons in the central nervous system (CNS) fail to do so, resulting in irreversible neurological disorders. To understand the mechanisms of axon regeneration, various experimental models have been utilized in vivo and in vitro. Here, we collate the key experimental models that revealed the important mechanisms regulating axon regeneration and degeneration in different systems. We also discuss the advantages of experimenting with the rodent model, considering the application of these findings in understanding human diseases and for developing therapeutic methods.
- 6 January 2021
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 22 (2) , 474
Open AccessExperimental Model Systems for Understanding Human Axonal Injury Responses
Neurons are structurally unique and have dendrites and axons that are vulnerable to injury. Some neurons in the peripheral nervous system (PNS) can regenerate their axons after injuries. However, most neurons in the central nervous system (CNS) fail to do so, resulting in irreversible neurological disorders. To understand the mechanisms of axon regeneration, various experimental models have been utilized in vivo and in vitro. Here, we collate the key experimental models that revealed the important mechanisms regulating axon regeneration and degeneration in different systems. We also discuss the advantages of experimenting with the rodent model, considering the application of these findings in understanding human diseases and for developing therapeutic methods.
- Open Access
- 17 June 2020
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 117 (27) , 15955-15966
The stem cell marker Prom1 promotes axon regeneration by down-regulating cholesterol synthesis via Smad signaling
Significance: This work presents a concept for promoting the neuronal regenerative potential by engineering the expression of a stem cell marker, Prom1 . We identify Prom1 as a developmentally down-regulated neuronal intrinsic factor of axon regeneration. Replenishing Prom1 expression amplifies the axonal regenerative potential by transcriptionally inhibiting cholesterol metabolism via Smad-dependent signaling. We provide evidence that a reduction in cholesterol synthesis empowers neuronal regrowth capacity. This work suggests that Food and Drug Administration-approved cholesterol-lowering drugs are potential candidates for neuroregenerative medicine.
- 17 June 2020
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 117 (27) , 15955-15966
Open AccessThe stem cell marker Prom1 promotes axon regeneration by down-regulating cholesterol synthesis via Smad signaling
Significance: This work presents a concept for promoting the neuronal regenerative potential by engineering the expression of a stem cell marker, Prom1 . We identify Prom1 as a developmentally down-regulated neuronal intrinsic factor of axon regeneration. Replenishing Prom1 expression amplifies the axonal regenerative potential by transcriptionally inhibiting cholesterol metabolism via Smad-dependent signaling. We provide evidence that a reduction in cholesterol synthesis empowers neuronal regrowth capacity. This work suggests that Food and Drug Administration-approved cholesterol-lowering drugs are potential candidates for neuroregenerative medicine.